Skip to main content
Clinical Trials/CTRI/2023/08/056112
CTRI/2023/08/056112Not yet recruitingPhase 3

EFFICACY OF DURVA TAILA UTTARBASTI IN THE MANAGEMENT OF STRICURE URETHRA AN OPEN LABELLED CLINICAL STUDY - NI

DR IMRANNABI JABBARALI NADAF0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Diagnosed cases of Stricture Urethra will be included
  • Patients of either gender of age 25 TO 75years with history of stricture urethra of mild to moderate symptoms will be selected for the study

Exclusion Criteria

  • Age group below 25 years and above 75 years
  • Patients of impacted calculus in the urethra and bladder Neck
  • Benign Prostatic Hyperplasia
  • Uncontrolled Diabetes Mellitus
  • Nephritic Syndrome and Neoplasm of lower urinary tract
  • Congenital and severely symptomatic Stricture Urethra
  • HIV and HbsAg positive
  • Carcinoma patients

Investigators

Sponsor
DR IMRANNABI JABBARALI NADAF

Similar Trials